Merck & Co., Inc. (NYSE:MRK) - Page 2

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

Stocks were indicated to open handily lower on Monday as China retaliated with new tariffs of its own against the United States. Investors have seen multiple reasons that might justify ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

Stocks were looking for direction on Thursday, a day after Fed Chair Jerome Powell promised to be patient on interest rates, and the S&P 500 and Nasdaq have effectively hit ...
Read Full Story »

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Five of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, with most coming out on Tuesday. The Dow is closing in ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

15 Great Dividend Stocks Retirees Should Own in 2019

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Shares of drug giant Pfizer Inc. (NYSE: PFE) have lagged rival Merck & Co. Inc. (NYSE: PFE). The gain of 23% for Pfizer from this time a year ago is ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 10 Companies Buying Back the Most Stock

The two most common methods of returning capital to shareholders are via dividends and share buybacks. Dividends have a straightforward benefit because they are sending income back to their investors, ...
Read Full Story »

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Friday brought on major selling in the stock market, with the Dow Jones industrials down over 400 points and the S&P 500 down almost 50 points earlier in the ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends

With earnings reports for the fourth quarter all but over, and the second quarter of 2019 well underway, many of the top companies we follow on Wall Street are making ...
Read Full Story »